SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 166 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $622,059 | -13.7% | 30,300 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $721,140 | +7.6% | 30,300 | -2.3% | 0.00% | 0.0% |
| Q4 2023 | $669,910 | +19.4% | 31,000 | +15.7% | 0.00% | 0.0% |
| Q2 2023 | $560,924 | +32.8% | 26,800 | +34.0% | 0.00% | 0.0% |
| Q1 2023 | $422,400 | +3.7% | 20,000 | +25.0% | 0.00% | 0.0% |
| Q4 2022 | $407,200 | +6.0% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $384,000 | -81.6% | 16,000 | -85.3% | 0.00% | -50.0% |
| Q2 2022 | $2,091,000 | +20.9% | 108,655 | +9.2% | 0.00% | +100.0% |
| Q1 2022 | $1,730,000 | +6.5% | 99,510 | +34.1% | 0.00% | 0.0% |
| Q4 2021 | $1,624,000 | – | 74,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |